Hutchin Hill Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hutchin Hill Capital's PFE Position: Q3 2017 in Review
Hutchin Hill Capital sold out of Pfizer (PFE) in Q3 2017, closing a stake of 19,710 shares — an estimated $628K sold.
Hutchin Hill Capital first reported a position in PFE in Q3 2013 and held it in 13 quarters. The position peaked at $19.4M in Q4 2015. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Hutchin Hill Capital reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
- Hutchin Hill Capital sold 19,710 Pfizer shares in Q3 2017, an estimated $628K.
- Hutchin Hill Capital first reported a position in Pfizer in Q3 2013 and held it in 13 quarters.
- Hutchin Hill Capital's Pfizer position peaked at $19.4M in Q4 2015.
- 2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.